Who are Bupivacaine with intrathecal morphine's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bupivacaine-with-intrathecal-morphine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Bupivacaine with intrathecal morphine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bupivacaine with intrathecal morphine (Bupivacaine with intrathecal morphine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic with intrathecal opioid. Area: Anesthesia and Pain Management.

marketed Local anesthetic with intrathecal opioid Voltage-gated sodium channels (bupivacaine); mu-opioid receptors (morphine) Anesthesia and Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Bupivacaine with intrathecal morphine (Bupivacaine with intrathecal morphine) — Centre Hospitalier Universitaire Vaudois. Bupivacaine blocks sodium channels in nerve fibers to provide local anesthesia, while intrathecal morphine binds to opioid receptors in the spinal cord to provide analgesia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bupivacaine with intrathecal morphine TARGET	Bupivacaine with intrathecal morphine	Centre Hospitalier Universitaire Vaudois	marketed	Local anesthetic with intrathecal opioid	Voltage-gated sodium channels (bupivacaine); mu-opioid receptors (morphine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic with intrathecal opioid class)

Centre Hospitalier Universitaire Vaudois · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bupivacaine with intrathecal morphine — Competitive Intelligence Brief. https://druglandscape.com/ci/bupivacaine-with-intrathecal-morphine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab